Literature DB >> 22122229

Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1.

Kerstin Y Beste1, Heike Burhenne, Volkhard Kaever, Johannes-Peter Stasch, Roland Seifert.   

Abstract

Soluble guanylyl cyclase (sGC) regulates several important physiological processes by converting GTP into the second-messenger cGMP. sGC has several structural and functional properties in common with adenylyl cyclases (ACs). Recently, we reported that membranous ACs and sGC are potently inhibited by 2',3'-O-(2,4,6-trinitrophenyl)-substituted purine and pyrimidine nucleoside 5'-triphosphates. Using a highly sensitive high-performance liquid chromatography-tandem mass spectrometry method, we report that highly purified recombinant sGC of rat possesses nucleotidyl cyclase activity. As opposed to GTP, ITP, XTP and ATP, the pyrimidine nucleotides UTP and CTP were found to be sGC substrates in the presence of Mn(2+). When Mg(2+) is used, sGC generates cGMP, cAMP, cIMP, and cXMP. In conclusion, soluble "guanylyl" cyclase possesses much broader substrate specificity than previously assumed. Our data have important implications for cyclic nucleotide-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22122229     DOI: 10.1021/bi201259y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  39 in total

1.  cCMP and cUMP occur in vivo.

Authors:  Heike Bähre; Christina Hartwig; Antje Munder; Sabine Wolter; Tane Stelzer; Bastian Schirmer; Ulrike Beckert; Dara W Frank; Burkhard Tümmler; Volkhard Kaever; Roland Seifert
Journal:  Biochem Biophys Res Commun       Date:  2015-03-31       Impact factor: 3.575

2.  The Influence of Nitric Oxide on Soluble Guanylate Cyclase Regulation by Nucleotides: ROLE OF THE PSEUDOSYMMETRIC SITE.

Authors:  Nur Başak Sürmeli; Frederike M Müskens; Michael A Marletta
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

3.  Is cIMP a second messenger with functions opposite to those of cGMP?

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-15       Impact factor: 3.000

4.  Tissues cIMPly do not lie.

Authors:  Yuansheng Gao; Paul M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-23       Impact factor: 3.000

5.  Activation of NQO-1 mediates the augmented contractions of isolated arteries due to biased activity of soluble guanylyl cyclase in their smooth muscle.

Authors:  Charlotte M S Detremmerie; Susan W S Leung; Paul M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-30       Impact factor: 3.000

6.  Recent progress in the field of cIMP research.

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-08-18       Impact factor: 3.000

7.  A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.

Authors:  Rachel A Getz; Grace Kwak; Stacie Cornell; Samuel Mbugua; Jeremy Eberhard; Sheng Xiang Huang; Zainab Abbasi; Ana Santos de Medeiros; Rony Thomas; Brett Bukowski; Patricia K Dranchak; James Inglese; Charles S Hoffman
Journal:  Cell Signal       Date:  2019-04-24       Impact factor: 4.315

8.  Regulation of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel activity by cCMP.

Authors:  Xiangang Zong; Stefanie Krause; Cheng-Chang Chen; Jens Krüger; Christian Gruner; Xiaochun Cao-Ehlker; Stefanie Fenske; Christian Wahl-Schott; Martin Biel
Journal:  J Biol Chem       Date:  2012-06-19       Impact factor: 5.157

9.  Heterogeneity of pulmonary endothelial cyclic nucleotide response to Pseudomonas aeruginosa ExoY infection.

Authors:  K A Morrow; R Seifert; V Kaever; A L Britain; S L Sayner; C D Ochoa; E A Cioffi; D W Frank; T C Rich; T Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-18       Impact factor: 5.464

10.  In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Authors:  Stephanie L Rolsma; Dara W Frank
Journal:  Methods Mol Biol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.